Home > Resources > Whitepapers > YOUR REFERENCE GUIDE TO THE ANALYSIS OF BIOPHARMACEUTICALS AND BIOMOLECULES

YOUR REFERENCE GUIDE TO THE ANALYSIS OF BIOPHARMACEUTICALS AND BIOMOLECULES

Biotherapeutics have enormous potential to improve human health. The number of approved protein and antibody therapeutics continues to grow around the world as this important therapeutic class addresses unmet medical needs. But discovery and development of biopharmaceuticals is difficult. You face a variety of challenges and must not only stay abreast of advances in knowledge and improvements in technology, but also navigate the maze of shifting government regulations.

Spotlight

Columbia Asia Hospitals Pvt. Ltd.

Columbia Asia is an international healthcare group operating a chain of modern hospitals across Asia. Columbia Asia Hospitals Pvt. Ltd.is one of the first healthcare companies to enter India through 100% foreign direct investment (FDI) route. The Columbia Asia Group is owned by more than 150 private equity companies, fund management organizations and individual investors.

OTHER WHITEPAPERS

Automated Extraction of High Molecular Weight DNA

whitePaper | November 14, 2019

SmartExtraction significantly simplifies the entire automated workflow of DNA extraction, setting new standards with regard to efficiency, yield and quality of the DNA.

BIOTECHNOLOGY UPDATE

whitePaper | April 24, 2022

The Global Forum on Biotechnology, established in 2010, is one of 15 Global Fora created by OECD Committees. Global Fora are not official OECD bodiesbut are best described as broad.

Establishment of the basidiomycete Fomes fomentarius for the production of composite materials

whitePaper | February 24, 2022

Filamentous fungi of the phylum Basidiomycota are considered as an attractive source for the biotech‑ nological production of composite materials. The ability of many basidiomycetes to accept residual lignocellulosic plant biomass from agriculture and forestry.

Considerations for migrating a drug product presentation from vial to pre-filled syringe

whitePaper | December 9, 2022

There is an upward trend for pharmaceutical companies to ask their contract development and manufacturing organisations (CDMO).

2022 Global Life Sciences Outlook

whitePaper | January 7, 2022

While valuations for the life sciences sector in this past year have been mixed, the underlying performance and outlook for the sector is healthy

Further Discussion on Plasmids to Establish Release Specifications Using a Risk-Based Approach to Manage Supply

whitePaper | December 6, 2022

BioPhorum’s mission is to create environments where the global biopharmaceutical industry can collaborate and accelerate its rate of progress, for the benefit of all.